2.46
1.60%
-0.04
Pre-market:
2.44
-0.02
-0.81%
Cronos Group Inc stock is currently priced at $2.46, with a 24-hour trading volume of 1.00M.
It has seen a -1.60% decreased in the last 24 hours and a -16.04% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $2.51 pivot point. If it approaches the $2.45 support level, significant changes may occur.
Previous Close:
$2.50
Open:
$2.52
24h Volume:
1.00M
Market Cap:
$939.75M
Revenue:
$87.89M
Net Income/Loss:
$-73.96M
P/E Ratio:
-6.4737
EPS:
-0.38
Net Cash Flow:
$-46.26M
1W Performance:
-1.60%
1M Performance:
-16.04%
6M Performance:
+25.51%
1Y Performance:
+39.77%
Cronos Group Inc Stock (CRON) Company Profile
Name
Cronos Group Inc
Sector
Phone
416-504-0004
Address
720 King Street West, Suite 320, Toronto, ON
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-02-22 | Initiated | Bernstein | Mkt Perform |
Jul-28-22 | Upgrade | Canaccord Genuity | Hold → Buy |
May-11-22 | Upgrade | CIBC | Neutral → Sector Outperform |
Mar-22-22 | Upgrade | Barclays | Underweight → Equal Weight |
Jan-27-22 | Upgrade | Jefferies | Underperform → Hold |
Nov-18-21 | Resumed | BofA Securities | Underperform |
Apr-28-21 | Resumed | BofA Securities | Underperform |
Feb-22-21 | Downgrade | CIBC | Sector Outperform → Neutral |
Jun-24-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
Apr-27-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
Apr-14-20 | Downgrade | Piper Sandler | Overweight → Neutral |
Apr-02-20 | Downgrade | BofA/Merrill | Buy → Neutral |
Mar-31-20 | Downgrade | Canaccord Genuity | Hold → Sell |
Mar-04-20 | Upgrade | MKM Partners | Neutral → Buy |
Mar-03-20 | Downgrade | Stifel | Buy → Hold |
Oct-18-19 | Upgrade | Stifel | Hold → Buy |
Sep-20-19 | Initiated | MKM Partners | Neutral |
Sep-05-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
Aug-13-19 | Initiated | Piper Jaffray | Overweight |
Aug-09-19 | Upgrade | Canaccord Genuity | Sell → Hold |
Jun-28-19 | Initiated | Consumer Edge Research | Equal Weight |
Jun-06-19 | Initiated | Stifel | Hold |
Jun-05-19 | Upgrade | BofA/Merrill | Underperform → Buy |
Apr-17-19 | Initiated | BofA/Merrill | Underperform |
Mar-27-19 | Downgrade | Canaccord Genuity | Hold → Sell |
Feb-25-19 | Initiated | Jefferies | Underperform |
Jan-18-19 | Initiated | CIBC | Sector Outperform |
View All
Cronos Group Inc Stock (CRON) Latest News
Cronos Group Inc. stock falls Thursday, underperforms market - MarketWatch
MarketWatch
Cronos Group Inc. stock rises Wednesday, still underperforms market - MarketWatch
MarketWatch
Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch
MarketWatch
Cronos Group Inc. stock rises Monday, outperforms market - MarketWatch
MarketWatch
Cronos Group (TSE:CRON) Shares Down 1.5% - Defense World
Defense World
Cronos Group (CVE:MJN) Trading Down 1.9% - Defense World
Defense World
Cronos Group Inc Stock (CRON) Financials Data
Cronos Group Inc (CRON) Revenue 2024
CRON reported a revenue (TTM) of $87.89 million for the quarter ending December 31, 2023, a -1.33% decline year-over-year.
Cronos Group Inc (CRON) Net Income 2024
CRON net income (TTM) was -$73.96 million for the quarter ending December 31, 2023, a +56.17% increase year-over-year.
Cronos Group Inc (CRON) Cash Flow 2024
CRON recorded a free cash flow (TTM) of -$46.26 million for the quarter ending December 31, 2023, a +50.78% increase year-over-year.
Cronos Group Inc (CRON) Earnings per Share 2024
CRON earnings per share (TTM) was -$0.1843 for the quarter ending December 31, 2023, a +59.04% growth year-over-year.
About Cronos Group Inc
Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations MMPR. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.
Cap:
|
Volume (24h):